Ranjit Kumar Sahoo

Learn More
INTRODUCTION The purpose of this study was to evaluate the effect of prognostic factors on the outcome of patients with MM after ASCT. PATIENTS AND METHODS We analyzed results of 170 consecutive patients (121 male and 49 female) of MM who underwent ASCT. Patients' median age was 52 years (range, 26-68 years). High dose melphalan (200 mg/m(2)) was used for(More)
The purpose of this study was to evaluate the efficacy and safety of a novel theranostic agent, 177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer (mCRPC). Thirty-one mCRPC patients with progressive disease despite second-line hormonal therapy and/or docetaxel chemotherapy were recruited for the study. All patients underwent(More)
BACKGROUND Survival of myeloma patients has improved considerably in the past decade. However, limited data are available on their long-term outcome. We analysed the data of 225 consecutive patients who underwent autologous stem cell transplantation (ASCT) at our centre. METHODS Between April 1990 and December 2013, a total of 225 patients with multiple(More)
OBJECTIVE Lu-DKFZ-PSMA-617, a urea-based compound, binds to the extracellular domain of prostate-specific membrane antigen, thus providing an effective target for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Before its therapeutic use, it is necessary that the radiation dosimetry of this radiopharmaceutical be studied to(More)
Extraskeletal osteosarcoma is a rare malignant soft tissue tumor. At open cholecystectomy performed for gallstones, a 45-year-old woman was found to have extraskeletal osteosarcoma on histopathological examination. 1 year after surgery, the patient is symptom free and all imaging studies are normal. After multidisciplinary discussion it was decided to give(More)
BACKGROUND & OBJECTIVES Primary central nervous system lymphomas (PCNSLs) are relatively uncommon, accounting for 2-3 per cent of primary brain tumours. Majority of these are diffuse large B cell lymphomas (DLBCL) occurring both in immunocompromised and immunocompetent patients. We undertook this study to classify PCNSL into germinal centre (GC) and(More)
n engl j med 377;19 nejm.org November 9, 2017 1901 have worked in the LEVO-CTS trial was that it was started soon before surgery (median, 20 minutes). However, the “pharmacokinetic and pharmacodynamic” information that Putzu et al. provided to support their hypothesis for a new study was reported in patients with heart failure1-3 rather than those(More)
CONTEXT AND AIM Data on HIV associated hematologic malignancies is sparse from India. This study attempts to analyze the spectrum and features of this disease at a tertiary cancer center in India. SETTING AND METHODS Retrospective study from case records of patients registered with a diagnosis of hematologic malignancy and HIV infection between January(More)